RE:PR - conference Let's hope he says something more professionally compelling than "mind boggling"! I hope he listens to how a SeaGen or Immunomedics spoke about their programs and uses their language. Best in class, entire platform based on target prevalence and activation, industry lead in SORT target, own the space now, reference the academic journals SORT stuff, forefront of investigating the importance of VM and how our MOA disrupts this, etc...
FredTheVoice wrote: THERATECHNOLOGIES TO PRESENT AT THE B. RILEY SECURITIES VIRTUAL ONCOLOGY INVESTOR CONFERENCE Montreal, Canada – January 14, 2021 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer and Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer will present at the B. Riley Virtual Oncology Investor Conference on Wednesday, January 20, 2021 at 3:30 p.m. ET. To access the live virtual presentation, please visit the ‘News’ section of the Company’s website. A webcast replay will also be available approximately two hours after the presentation.
FTV.